Halo University: AUR102 Why upgrading to Aura can help with your SVP analysis
The Aura® suite of instruments was released onto the market in 2020. Since then, this platform has seen significant growth in adoption…
Read MoreGEN – Ultra-Low Volume Biophysical Characterization for Viral Vectors and LNPs
Subvisible aggregates are a critical quality attribute (CQA) and a key measure of physical stability for all biologics. Aggregates are…
Read MoreDTR – Complete Aggregate and Particle Characterization of Protein, Gene, and Cell Therapies
In this webinar, our key speaker Dikran Khachadourian, will discuss how Aura® incorporates the techniques of Backgrounded Membrane Imaging (BMI)…
Read MoreComplete Characterization of Subvisible Aggregates and Impurities in Protein, Gene, and Cell Therapies Using Aura+
In all biological products, distinguishing aggregated API from other particle types matters for understanding the root cause of instability. Until…
Read MoreApp Note 22: Detecting Glass Particles – Making the Invisible Visible to Avoid the Leading Cause of Drug Recalls
Please fill out the form to download the app note.
Read MoreIdentification of Stable Cell and Gene Therapeutics and Characterization of Subvisible Aggregates
In all biologics, subvisible aggregates are a critical quality attribute and key indicator of product stability. Here we present the…
Read MoreHalo U: FMM 201 and SMI 301: Subvisible Particle Identification using Side-Illumination and Fluorescence Membrane Microscopy on Protein Therapeutic Formulations
Subvisible particles are a critical quality attribute (CQA) for protein therapeutics that can limit a product’s shelf-life and induce immunogenicity.…
Read MoreTech Note 5: SIMI: A Different Approach to Revealing Dangerous Subvisible Impurities
Please fill out the form to download the tech note.
Read MoreGene Therapy: Critical Quality Attributes of Viral Vector and Lipid Nanoparticle Stability
There is a growing appreciation that the biggest hurdle toward realizing the full clinical potential of human gene therapy and…
Read MoreParticle Vue 21 CFR Part 11 Documentation
Download PDF
Read More